You can buy or sell Neogen and other stocks, options, ETFs, and crypto commission-free!
Neogen Corp. engages in the development, manufacture, and sale of products dedicated to food and animal safety. It operates through the following segments: Food Safety, Animal Safety, and Corporate. Read More The Food Safety segment consists of the development, production and marketing of diagnostic test kits, dehydrated culture media and related products used by food producers and processors to detect harmful natural toxins, foodborne bacteria, allergens, drug residues, and levels of general sanitation. The Animal Safety segment includes the development, production and marketing of products dedicated to animal safety, including a complete line of consumable products marketed to veterinarians and animal health product distributors. The Corporate segment refers to the corporate assets, including cash and cash equivalents, marketable securities, current and deferred tax accounts, and overhead expenses not allocated to specific business segments. The company was founded on June 30, 1981 and is headquartered in Lansing, MI.
52 Week High
52 Week Low
Advertising and Marketing
Neogen slides ~14% on Q3 earnings miss
Neogen slips (NEOG -13.8% ) as the company says that Q3 results reflect various challenges, including continued weakness in the global animal protein market and currency headwinds Animal Safety segment revenue decreases 2% to ~$47M due to lower sales to distributor partners into the animal protein market, including rodent and insect control products Food Safety segment sales is +8% to $51M, with rapid diagnostics revenues up 17% Gross margin declines 130bps Y/Y to 45.7% primarily as a result of mix shift...
Neogen: Fiscal 3Q Earnings Snapshot
LANSING, Mich. (AP) _ Neogen Corp. (NEOG) on Tuesday reported fiscal third-quarter earnings of $13.1 million. The Lansing, Michigan-based company said it had profit of 25 cents per share. The results missed Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for earnings of 27 cents per share. Scroll to continue with content Ad The maker of medical testing kits posted revenue of $97.7 million in the period, also falling short of Street forecasts. Th...
Neogen reports third quarter results
LANSING, Mich., March 26, 2019 /PRNewswire/ -- Neogen Corporation (NEOG) announced today that its revenues for the third quarter of its 2019 fiscal year, which ended Feb. 28, were $97,700,000, up 3% from the previous year's third quarter revenues of $94,903,000. Current year-to-date revenues were $304,424,000, up 5% compared to $289,811,000 for the same period a year ago. Third quarter net income was $13,073,000, compared to the prior year's $16,586,000. Earnings per share in the current quarter were $0.25...
$0.27 per share
$0.25 per share